What is Mast Pharmacies?
Established in 1964, Mast Pharmacies has evolved into a cornerstone of community health, specializing in the administration of prescription drugs and personalized patient care. By prioritizing a high-touch, individual-focused service model, the company has differentiated itself from larger, impersonal retail chains. Their operational philosophy centers on professional excellence and a deep-seated commitment to addressing the specific medical needs of their local clientele, effectively bridging the gap between clinical pharmaceutical services and community-based support.
How much funding has Mast Pharmacies raised?
Mast Pharmacies has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Mast Pharmacies
PPP
Public-Private Partnership
What's next for Mast Pharmacies?
The infusion of capital signals a transition into a more aggressive growth phase, likely focused on optimizing supply chain efficiencies and potentially expanding its physical footprint. As the company navigates this late-stage development, the strategic focus will likely shift toward integrating advanced pharmacy management technologies and enhancing patient engagement platforms. By maintaining its reputation for kindness and professionalism, Mast Pharmacies is poised to solidify its status as a trusted healthcare provider, ensuring long-term sustainability and competitive relevance in an increasingly consolidated pharmaceutical market.
See full Mast Pharmacies company page
